Results 41 to 50 of about 3,230,451 (211)

Tissue-specific regulation of IRS-1 in unilaterally nephrectomized rats

open access: yesBrazilian Journal of Medical and Biological Research, 1997
Insulin stimulates the tyrosine kinase activity of its receptor, resulting in the phosphorylation of its cytosolic substrate, insulin receptor substrate 1 (IRS-1).
A.D. Sasse   +5 more
doaj   +1 more source

Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

open access: yesCell Death and Disease, 2022
Synaptic loss, neuronal death, and circuit remodeling are common features of central nervous system neurodegenerative disorders. Retinitis pigmentosa (RP), the leading cause of inherited blindness, is a group of retinal dystrophies characterized by ...
Alonso Sánchez-Cruz   +9 more
doaj   +1 more source

Insulin signaling and its application

open access: yesFrontiers in Endocrinology, 2023
The discovery of insulin in 1921 introduced a new branch of research into insulin activity and insulin resistance. Many discoveries in this field have been applied to diagnosing and treating diseases related to insulin resistance.
Thi Kim Chung Le   +9 more
doaj   +1 more source

Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes

open access: yesHaematologica, 2012
Background In normal platelets, insulin inhibits agonist-induced Ca2+ mobilization by raising cyclic AMP. Platelet from patients with type 2 diabetes are resistant to insulin and show increased Ca2+ mobilization, aggregation and procoagulant activity. We
Anja J. Gerrits   +5 more
doaj   +1 more source

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier

open access: yesEndocrinology, Diabetes & Metabolism, 2020
Introduction CNS insulin levels are decreased and insulin receptor signalling is dampened in Alzheimer's disease (AD). Increasing CNS insulin levels through a variety of methods has been shown to improve memory.
Demi C. Galindo   +2 more
doaj   +1 more source

New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics

open access: yesJournal of Pharmacological Sciences, 2005
Long after the pioneering studies documenting the existence of insulin (year 1967) and insulin receptor (year 1978) in brain, the last decade has witnessed extraordinary progress in the understanding of brain region-specific multiple roles of insulin ...
Akihiko Wada   +3 more
doaj   +1 more source

The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43

open access: yesNature Communications, 2013
The gut microbiota affects nutrient acquisition and energy regulation of the host, and can influence the development of obesity, insulin resistance, and diabetes.
I. Kimura   +14 more
semanticscholar   +1 more source

Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions

open access: yesLife, 2021
Current hypotheses implicate insulin resistance of the brain as a pathogenic factor in the development of Alzheimer’s disease and other dementias, Parkinson’s disease, type 2 diabetes, obesity, major depression, and traumatic brain injury.
Igor Pomytkin, Vsevolod Pinelis
doaj   +1 more source

Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle*

open access: yesJournal of Biological Chemistry, 2002
Recent studies have demonstrated that fatty acids induce insulin resistance in skeletal muscle by blocking insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase (PI3-kinase). To examine the mechanism by which
Chunli Yu   +13 more
semanticscholar   +1 more source

ATP sensitizes the insulin receptor to insulin. [PDF]

open access: yesProceedings of the National Academy of Sciences, 1988
Insulin receptor with high insulin binding and tyrosine kinase activities has been prepared from human placenta. Based on a molecular mass of 306 kDa for the receptor (the value obtained from the sum of the amino acid residues), this preparation is capable of binding 1.48 mol of insulin per mol of receptor.
Kevin D. Ridge   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy